Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue
Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue Byung-Soo Youn 1 , Sa-Ik Bang 2 , Nora Klöting 3 , Ji Woo Park 1 , Namseok Lee 1 , Ji-Eun Oh 1 , Kyung-Bae Pi 1 , Tae Hee Lee 4 , Karen Ruschke 3 , Mathias Fasshauer 3 , Michael Stumvoll 3 and...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 58; no. 3; pp. 627 - 636 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.03.2009
|
Subjects | |
Online Access | Get full text |
ISSN | 0012-1797 1939-327X 1939-327X |
DOI | 10.2337/db08-1147 |
Cover
Loading…
Abstract | Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue
Byung-Soo Youn 1 ,
Sa-Ik Bang 2 ,
Nora Klöting 3 ,
Ji Woo Park 1 ,
Namseok Lee 1 ,
Ji-Eun Oh 1 ,
Kyung-Bae Pi 1 ,
Tae Hee Lee 4 ,
Karen Ruschke 3 ,
Mathias Fasshauer 3 ,
Michael Stumvoll 3 and
Matthias Blüher 3
1 AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea
2 Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3 Department of Medicine, University of Leipzig, Leipzig, Germany
4 Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea
Corresponding authors: Matthias Blüher, bluma{at}medizin.uni-leipzig.de , and Byung-Soo Youn, bsyoun{at}adipogen.com
Abstract
OBJECTIVE— Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central
obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia
is unknown.
RESEARCH DESIGN AND METHODS— For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using
this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body
fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose
tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression
was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction)
from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro
was performed using THP-1–based cell migration assays.
RESULTS— Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese
subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage
infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol.
Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin.
The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent
of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly
decreased circulating progranulin levels.
CONCLUSIONS— Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia.
We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental
adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients
with type 2 diabetes.
Footnotes
Published ahead of print at http://diabetes.diabetesjournals.org on 3 December 2008.
B.-S.Y. and S.-I.B. contributed equally to this study.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work
is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore
be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Accepted November 19, 2008.
Received August 22, 2008.
DIABETES |
---|---|
AbstractList | OBJECTIVE—Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown.
RESEARCH DESIGN AND METHODS—For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1–based cell migration assays.
RESULTS—Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels.
CONCLUSIONS—Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue Byung-Soo Youn 1 , Sa-Ik Bang 2 , Nora Klöting 3 , Ji Woo Park 1 , Namseok Lee 1 , Ji-Eun Oh 1 , Kyung-Bae Pi 1 , Tae Hee Lee 4 , Karen Ruschke 3 , Mathias Fasshauer 3 , Michael Stumvoll 3 and Matthias Blüher 3 1 AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea 2 Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 3 Department of Medicine, University of Leipzig, Leipzig, Germany 4 Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea Corresponding authors: Matthias Blüher, bluma{at}medizin.uni-leipzig.de , and Byung-Soo Youn, bsyoun{at}adipogen.com Abstract OBJECTIVE— Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. RESEARCH DESIGN AND METHODS— For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1–based cell migration assays. RESULTS— Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. CONCLUSIONS— Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. Footnotes Published ahead of print at http://diabetes.diabetesjournals.org on 3 December 2008. B.-S.Y. and S.-I.B. contributed equally to this study. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Accepted November 19, 2008. Received August 22, 2008. DIABETES Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown.OBJECTIVEProgranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown.For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1-based cell migration assays.RESEARCH DESIGN AND METHODSFor the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1-based cell migration assays.Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Galpha. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels.RESULTSProgranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Galpha. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels.Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes.CONCLUSIONSElevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. OBJECTIVE--Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. RESEARCH DESIGN AND METHODS--For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-l-based cell migration assays. RESULTS--Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. CONCLUSIONS--Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. Diabetes 58:627-636, 2009 Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1-based cell migration assays. Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Galpha. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1-based cell migration assays. Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Galpha. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. OBJECTIVE— Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances; however, the role of circulating progranulin in human obesity, type 2 diabetes, and dyslipidemia is unknown. RESEARCH DESIGN AND METHODS— For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA). Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of obesity, body fat distribution, insulin sensitivity, and glucose tolerance and in 60 individuals with normal (NGT) or impaired (IGT) glucose tolerance or type 2 diabetes before and after a 4-week physical training program. Progranulin mRNA and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or obese individuals. Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using THP-1–based cell migration assays. RESULTS— Progranulin serum concentrations were significantly higher in individuals with type 2 diabetes compared with NGT and in obese subjects with predominant visceral fat accumulation. Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol. Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin. The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Gα. Moreover, in type 2 diabetes, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels. CONCLUSIONS— Elevated progranulin serum concentrations are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. We identified progranulin as a novel marker of chronic inflammation in obesity and type 2 diabetes that closely reflects omental adipose tissue macrophage infiltration. Physical training significantly reduces elevated circulating progranulin in patients with type 2 diabetes. |
Audience | Professional |
Author | Ji Woo Park Tae Hee Lee Nora Klöting Kyung-Bae Pi Byung-Soo Youn Ji-Eun Oh Sa-Ik Bang Mathias Fasshauer Namseok Lee Matthias Blüher Karen Ruschke Michael Stumvoll |
AuthorAffiliation | 3 Department of Medicine, University of Leipzig, Leipzig, Germany 2 Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 1 AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea 4 Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea |
AuthorAffiliation_xml | – name: 3 Department of Medicine, University of Leipzig, Leipzig, Germany – name: 4 Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea – name: 2 Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – name: 1 AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea |
Author_xml | – sequence: 1 givenname: Byung-Soo surname: Youn fullname: Youn, Byung-Soo organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea – sequence: 2 givenname: Sa-Ik surname: Bang fullname: Bang, Sa-Ik organization: Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea – sequence: 3 givenname: Nora surname: Klöting fullname: Klöting, Nora organization: Department of Medicine, University of Leipzig, Leipzig, Germany – sequence: 4 givenname: Ji Woo surname: Park fullname: Park, Ji Woo organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea – sequence: 5 givenname: Namseok surname: Lee fullname: Lee, Namseok organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea – sequence: 6 givenname: Ji-Eun surname: Oh fullname: Oh, Ji-Eun organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea – sequence: 7 givenname: Kyung-Bae surname: Pi fullname: Pi, Kyung-Bae organization: AdipoGen, College of Life Science and Biotechnology, Korea University, Seoul, Korea – sequence: 8 givenname: Tae Hee surname: Lee fullname: Lee, Tae Hee organization: Formulae Pharmacology Department, Oriental Medical School, Kyungwon University, Seong Nam City, Kyunggi-Do, Korea – sequence: 9 givenname: Karen surname: Ruschke fullname: Ruschke, Karen organization: Department of Medicine, University of Leipzig, Leipzig, Germany – sequence: 10 givenname: Mathias surname: Fasshauer fullname: Fasshauer, Mathias organization: Department of Medicine, University of Leipzig, Leipzig, Germany – sequence: 11 givenname: Michael surname: Stumvoll fullname: Stumvoll, Michael organization: Department of Medicine, University of Leipzig, Leipzig, Germany – sequence: 12 givenname: Matthias surname: Blüher fullname: Blüher, Matthias organization: Department of Medicine, University of Leipzig, Leipzig, Germany |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21204963$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19056610$$D View this record in MEDLINE/PubMed |
BookMark | eNptkl2L1DAUhousuB964R-QIigodDdJ26S9EcZB14WREVzRu5BJTjtZ02RsWnX_vWecccdZhhD6kee8Sd7zniZHPnhIkqeUnLM8FxdmQaqM0kI8SE5onddZzsS3o-SEEMoyKmpxnJzGeEMI4TgeJce0JiXnlJwk3z9DP3bppz60vfKjsz6dBq_BD70abPAx_ahu07eQTmIM2qoBTPrVDkv8rfuwWqoW0ivfWLfl8WMI6bxDAeXSibGrECG9tjGO8Dh52CgX4cn2eZZ8ef_uevohm80vr6aTWaY5LYZsUdOiqpu8MbluGlVy4IwKyo1Zz5IJUEywsqoMAAIV0ELzwqiG4oJpVH6WvNnorsZFB2ZzGSdXve1UfyuDsnJ_xdulbMNPyXiBBlEUeLkV6MOPEeIgOxs1OKc8hDFKzmtREEYQfH4PvAlj7_FyklFeCF5XBULZBmqVA2l9E3BT3YIH3BsbieaBnNC6ZFxgs5A_P8DjMNBZfbDg1V4BMgP8Hlo1xiiry9k-mx1idXAOWpDYh-l8n3_2v5d3Jv5LEAIvtoCKWrkGU6RtvOMYZaSoeb47JMYmxh6anRSR6xTLdYrlOsXIXtxjtR3-xgudsO5gxetNxdK2y1-2B2msWsAAcfdSVjKXnIn8D__FAiA |
CODEN | DIAEAZ |
CitedBy_id | crossref_primary_10_1007_s00125_013_3139_y crossref_primary_10_1093_jnen_nlz022 crossref_primary_10_1371_journal_pone_0099785 crossref_primary_10_1080_15384101_2015_1041686 crossref_primary_10_1111_pedi_12915 crossref_primary_10_1186_1475_2840_13_14 crossref_primary_10_1016_j_ddmec_2013_09_002 crossref_primary_10_1111_nyas_14568 crossref_primary_10_1186_s43044_020_00063_3 crossref_primary_10_1530_JME_15_0075 crossref_primary_10_20945_2359_3997000000022 crossref_primary_10_1152_ajpendo_00297_2015 crossref_primary_10_1002_ehf2_12678 crossref_primary_10_18585_inabj_v5i2_59 crossref_primary_10_1093_gerona_glac018 crossref_primary_10_1080_09513590_2021_1958311 crossref_primary_10_3389_fimmu_2018_02952 crossref_primary_10_1016_j_jcte_2014_07_005 crossref_primary_10_1016_j_ajpath_2010_11_002 crossref_primary_10_1007_s00109_020_01942_7 crossref_primary_10_1371_journal_pone_0039880 crossref_primary_10_1016_j_cytogfr_2023_11_001 crossref_primary_10_1016_j_tem_2013_08_003 crossref_primary_10_1016_j_cyto_2019_154796 crossref_primary_10_3390_ijms25031815 crossref_primary_10_3233_JAD_170747 crossref_primary_10_1136_thoraxjnl_2018_211916 crossref_primary_10_3390_molecules25040775 crossref_primary_10_3109_14767058_2013_853734 crossref_primary_10_1371_journal_pone_0013911 crossref_primary_10_1186_s12920_023_01752_z crossref_primary_10_1007_s40200_019_00406_1 crossref_primary_10_1007_s11033_013_2804_z crossref_primary_10_1002_dmrr_1034 crossref_primary_10_1155_2013_803240 crossref_primary_10_1016_j_bcp_2022_115324 crossref_primary_10_1007_s11892_018_1110_5 crossref_primary_10_1007_s11481_013_9495_z crossref_primary_10_1016_j_diabres_2016_07_017 crossref_primary_10_1371_journal_pone_0055744 crossref_primary_10_3389_fncel_2022_874258 crossref_primary_10_3389_fendo_2022_873699 crossref_primary_10_1007_s40496_018_0177_z crossref_primary_10_1080_14728222_2018_1487951 crossref_primary_10_1189_jlb_0812429 crossref_primary_10_1007_s00784_014_1308_0 crossref_primary_10_1055_a_2106_6930 crossref_primary_10_1210_en_2011_1221 crossref_primary_10_1515_hmbci_2019_0050 crossref_primary_10_1038_s41467_024_48914_w crossref_primary_10_2217_bmm_09_82 crossref_primary_10_1016_j_drudis_2014_06_021 crossref_primary_10_1016_j_ejogrb_2017_09_017 crossref_primary_10_1515_jpem_2016_0378 crossref_primary_10_1371_journal_pone_0076679 crossref_primary_10_1530_EJE_12_0060 crossref_primary_10_1210_me_2014_1266 crossref_primary_10_1016_j_cmet_2011_12_002 crossref_primary_10_2337_dc11_1267 crossref_primary_10_1016_j_bbrc_2011_10_060 crossref_primary_10_1007_s12035_012_8380_8 crossref_primary_10_1007_s12031_011_9553_z crossref_primary_10_1042_CS20160005 crossref_primary_10_1111_eci_12558 crossref_primary_10_1155_2018_1251345 crossref_primary_10_1007_s41972_021_00129_7 crossref_primary_10_1371_journal_pone_0065542 crossref_primary_10_34172_joddd_2020_029 crossref_primary_10_1111_jgs_17604 crossref_primary_10_3389_fcell_2022_836196 crossref_primary_10_1002_trc2_12452 crossref_primary_10_1038_srep20356 crossref_primary_10_1074_jbc_M112_441949 crossref_primary_10_1093_cvr_cvt178 crossref_primary_10_1371_journal_pone_0239061 crossref_primary_10_1507_endocrj_EJ14_0210 crossref_primary_10_1002_jcp_25855 crossref_primary_10_1371_journal_pone_0192959 crossref_primary_10_1155_2015_740357 crossref_primary_10_15407_ubj85_03_010 crossref_primary_10_1016_j_cca_2019_07_006 crossref_primary_10_1515_jpem_2017_0321 crossref_primary_10_1080_21655979_2019_1607126 crossref_primary_10_3389_fphys_2020_578966 crossref_primary_10_1002_dneu_22499 crossref_primary_10_3390_biology10050400 crossref_primary_10_1016_j_soard_2020_06_056 crossref_primary_10_1016_j_crneur_2023_100094 crossref_primary_10_1080_13543784_2024_2349286 crossref_primary_10_3390_medicina60071165 crossref_primary_10_1507_endocrj_EJ20_0037 crossref_primary_10_3389_fnmol_2021_713031 crossref_primary_10_4103_tjd_tjd_67_21 crossref_primary_10_1016_j_metabol_2014_10_016 crossref_primary_10_1155_2015_357279 crossref_primary_10_2337_dc12_0220 crossref_primary_10_1210_en_2014_1058 crossref_primary_10_1159_000448896 crossref_primary_10_2217_clp_09_86 crossref_primary_10_1371_journal_pone_0238877 crossref_primary_10_4093_dmj_2012_36_5_317 crossref_primary_10_3390_metabo15030169 crossref_primary_10_1016_j_biopha_2023_114847 crossref_primary_10_1152_ajpendo_00586_2009 crossref_primary_10_1007_s00401_009_0616_y crossref_primary_10_1371_journal_pone_0165177 crossref_primary_10_1074_jbc_RA119_011164 crossref_primary_10_1111_nyas_14905 crossref_primary_10_1016_j_ejps_2022_106215 crossref_primary_10_1016_j_soard_2020_09_007 crossref_primary_10_1515_rjim_2016_0034 crossref_primary_10_1186_s12974_021_02203_1 crossref_primary_10_1007_s12031_011_9569_4 crossref_primary_10_1093_hmg_ddx413 crossref_primary_10_3390_nu13114125 crossref_primary_10_3892_etm_2021_10772 crossref_primary_10_1164_rccm_201601_0056OC crossref_primary_10_1007_s00404_014_3296_3 crossref_primary_10_1016_j_bbrc_2010_08_049 crossref_primary_10_1155_2013_360190 crossref_primary_10_1155_2018_3729402 crossref_primary_10_2147_BCTT_S406685 crossref_primary_10_1210_en_2018_00842 crossref_primary_10_1016_j_jns_2010_10_009 crossref_primary_10_1111_cen_14040 crossref_primary_10_1186_s13098_015_0112_6 crossref_primary_10_3389_fendo_2022_849457 crossref_primary_10_1186_s12950_023_00327_0 crossref_primary_10_4274_MMJ_galenos_2022_10270 crossref_primary_10_1016_j_tips_2015_04_014 crossref_primary_10_1016_j_cyto_2016_08_007 crossref_primary_10_1167_tvst_13_7_9 crossref_primary_10_1080_19420862_2015_1118596 crossref_primary_10_1093_gerona_glaa284 crossref_primary_10_2478_rjdnmd_2013_0022 |
Cites_doi | 10.1093/brain/awn012 10.1080/08977190701781222 10.1016/j.cmet.2007.06.002 10.1016/0026-0495(87)90063-1 10.1016/S0939-4753(04)80048-6 10.1016/S0140-6736(05)66378-7 10.1007/s00125-008-0928-9 10.1016/S0006-291X(03)01452-9 10.1210/jc.2004-1696 10.1210/jc.2006-1811 10.1002/humu.20651 10.1158/0008-5472.CAN-03-2364 10.1038/nature05485 10.2337/diabetes.54.8.2277 10.1038/nature05016 10.1210/edrv.21.6.0415 10.1016/j.bbrc.2006.01.012 10.1172/JCI26498 10.1073/pnas.0601752103 10.1110/ps.073295308 10.1042/bst0290072 10.1038/nm816 10.1007/s00109-003-0474-3 10.1089/met.2004.2.82 10.1152/physrev.90100.2007 10.1172/JCI200319246 10.2337/db06-0133 10.1074/jbc.M601284200 10.1017/S0007114500000982 10.1530/eje.1.02127 10.1038/nature05017 10.1111/j.1471-4159.2007.04968.x 10.1038/sj.ijo.0803632 10.1007/s00125-001-0723-3 |
ContentType | Journal Article |
Copyright | 2009 INIST-CNRS COPYRIGHT 2009 American Diabetes Association Copyright American Diabetes Association Mar 2009 Copyright © 2009, American Diabetes Association |
Copyright_xml | – notice: 2009 INIST-CNRS – notice: COPYRIGHT 2009 American Diabetes Association – notice: Copyright American Diabetes Association Mar 2009 – notice: Copyright © 2009, American Diabetes Association |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 8GL 3V. 7RV 7X7 7XB 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9- K9. KB0 LK8 M0R M0S M1P M2O M2P M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U S0X 7X8 5PM |
DOI | 10.2337/db08-1147 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: High School ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Consumer Health Database Health & Medical Collection (Alumni) Medical Database Research Library Science Database Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest Science Journals ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Research Library Prep MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
EndPage | 636 |
ExternalDocumentID | PMC2646061 1669437401 A195267179 19056610 21204963 10_2337_db08_1147 diabetes_58_3_627 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | South Korea |
GeographicLocations_xml | – name: South Korea |
GroupedDBID | - 08R 0R 1AW 29F 2WC 3V. 4.4 53G 55 5GY 5RE 5RS 5VS 7RV 7X7 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8GL 8R4 8R5 AAQQT AAWTL AAYEP AAYJJ ABFLS ABOCM ABPTK ABUWG ACDCL ACGOD ACPRK ADACO ADBBV ADBIT AENEX AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBAFP BBNVY BCR BCU BEC BENPR BES BHPHI BKEYQ BKNYI BLC BPHCQ BVXVI C1A CS3 DIK DU5 DWQXO E3Z EBS EDB EJD EX3 F5P FRP FYUFA GICCO GJ GNUQQ GUQSH GX1 H13 HCIFZ HZ H~9 IAG IAO IEA IHR INH INR IOF IPO K-O K9- KM KQ8 L7B LK8 M0R M1P M2O M2P M2Q M5 M7P MBDVC O0- O5R O5S O9- OB3 OBH OK1 OVD P2P PADUT PCD PEA PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q2X RHF RHI RPM S0X SJFOW SJN SV3 TDI WH7 WOQ WOW X7M XZ ZA5 ZY1 --- .55 .GJ .XZ 08P 0R~ 18M 354 6PF AAFWJ AAKAS AAYOK AAYXX ACGFO ADGHP ADZCM AEGXH AERZD AIAGR AIZAD ALIPV BTFSW CCPQU CITATION EMOBN HMCUK HZ~ ITC K2M M5~ N4W NAPCQ OHH PHGZM PHGZT TEORI TR2 UKHRP VVN W8F YFH YHG YOC ~KM 1CY 8F7 AFFNX AI. IQODW J5H MVM PJZUB PPXIY PQGLB VH1 XOL YQJ ZGI ZXP CGR CUY CVF ECM EIF NPM PMFND 7XB 8FK K9. PKEHL Q9U 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c614t-b91489f3fd3cffa56e621716dd16dd527ea272588deecff8e14c64daf1ea2dfa3 |
IEDL.DBID | 7X7 |
ISSN | 0012-1797 1939-327X |
IngestDate | Thu Aug 21 14:07:41 EDT 2025 Fri Sep 05 03:37:24 EDT 2025 Fri Jul 25 19:33:35 EDT 2025 Fri Jun 13 00:46:53 EDT 2025 Tue Jun 10 21:31:04 EDT 2025 Fri Jun 27 05:33:29 EDT 2025 Tue Jun 10 20:05:56 EDT 2025 Thu Apr 03 06:58:12 EDT 2025 Mon Jul 21 09:15:33 EDT 2025 Tue Jul 01 03:04:00 EDT 2025 Thu Apr 24 23:10:17 EDT 2025 Fri Jan 15 19:45:50 EST 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Endocrinopathy Serum Adipose tissue Diabetes mellitus Macrophage |
Language | English |
License | CC BY 4.0 Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c614t-b91489f3fd3cffa56e621716dd16dd527ea272588deecff8e14c64daf1ea2dfa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Published ahead of print at http://diabetes.diabetesjournals.org on 3 December 2008. Corresponding authors: Matthias Blüher, bluma@medizin.uni-leipzig.de, and Byung-Soo Youn, bsyoun@adipogen.com B.-S.Y. and S.-I.B. contributed equally to this study. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC2646061 |
PMID | 19056610 |
PQID | 216476984 |
PQPubID | 34443 |
PageCount | 10 |
ParticipantIDs | pascalfrancis_primary_21204963 pubmed_primary_19056610 proquest_journals_216476984 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2646061 gale_infotracacademiconefile_A195267179 crossref_citationtrail_10_2337_db08_1147 gale_infotracgeneralonefile_A195267179 gale_incontextgauss_8GL_A195267179 crossref_primary_10_2337_db08_1147 highwire_diabetes_diabetes_58_3_627 gale_incontextcollege_GICCO_A195267179 proquest_miscellaneous_66974020 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-03-01 |
PublicationDateYYYYMMDD | 2009-03-01 |
PublicationDate_xml | – month: 03 year: 2009 text: 2009-03-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Alexandria, VA |
PublicationPlace_xml | – name: Alexandria, VA – name: United States – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationTitleAlternate | Diabetes |
PublicationYear | 2009 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | 2022031208305031500_R20 2022031208305031500_R21 2022031208305031500_R22 2022031208305031500_R23 2022031208305031500_R24 2022031208305031500_R25 2022031208305031500_R26 2022031208305031500_R27 2022031208305031500_R28 2022031208305031500_R29 2022031208305031500_R6 2022031208305031500_R19 2022031208305031500_R7 2022031208305031500_R4 2022031208305031500_R5 2022031208305031500_R2 2022031208305031500_R3 2022031208305031500_R1 2022031208305031500_R30 2022031208305031500_R31 2022031208305031500_R10 2022031208305031500_R32 2022031208305031500_R11 2022031208305031500_R33 2022031208305031500_R12 2022031208305031500_R34 2022031208305031500_R13 2022031208305031500_R35 2022031208305031500_R14 2022031208305031500_R15 2022031208305031500_R16 2022031208305031500_R8 2022031208305031500_R17 2022031208305031500_R9 2022031208305031500_R18 12928786 - J Mol Med (Berl). 2003 Oct;81(10):600-12 12017675 - Diabetes Care. 2000 Jan;23 Suppl 1:S4-19 17593905 - Int J Obes (Lond). 2007 Sep;31(9):1420-8 16862116 - Nature. 2006 Aug 24;442(7105):916-9 18251005 - Diabetologia. 2008 Apr;51(4):641-7 18157829 - Hum Mutat. 2008 Jan;29(1):53-8 16046292 - Diabetes. 2005 Aug;54(8):2277-86 10889795 - Br J Nutr. 2000 Mar;83 Suppl 1:S71-7 16731817 - Diabetes. 2006 Jun;55(6):1554-61 17374712 - J Clin Endocrinol Metab. 2007 Jun;92(6):2240-7 14996734 - Cancer Res. 2004 Mar 1;64(5):1737-43 16556721 - Eur J Endocrinol. 2006 Apr;154(4):577-85 18359860 - Protein Sci. 2008 Apr;17(4):711-24 18245784 - Brain. 2008 Mar;131(Pt 3):732-46 12524533 - Nat Med. 2003 Feb;9(2):225-9 18370640 - Metab Syndr Relat Disord. 2004 Jun;2(2):82-104 11133069 - Endocr Rev. 2000 Dec;21(6):697-738 3796297 - Metabolism. 1987 Jan;36(1):54-9 14679176 - J Clin Invest. 2003 Dec;112(12):1796-808 17953663 - J Neurochem. 2008 Jan;104(2):287-97 16427608 - Biochem Biophys Res Commun. 2006 Mar 10;341(2):507-14 17618858 - Cell Metab. 2007 Jul;6(1):79-87 11935152 - Diabetologia. 2002 Feb;45(2):210-6 18092235 - Growth Factors. 2007 Aug;25(4):280-5 16862115 - Nature. 2006 Aug 24;442(7105):920-4 15836891 - Lancet. 2005 Apr 16-22;365(9468):1415-28 15673055 - Nutr Metab Cardiovasc Dis. 2004 Oct;14(5):228-32 16617105 - Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6676-81 18923185 - Physiol Rev. 2008 Oct;88(4):1379-406 15671098 - J Clin Endocrinol Metab. 2005 Apr;90(4):2282-9 11356130 - Biochem Soc Trans. 2001 May;29(Pt 2):72-5 16691291 - J Clin Invest. 2006 Jun;116(6):1494-505 12914763 - Biochem Biophys Res Commun. 2003 Aug 29;308(3):409-13 16809344 - J Biol Chem. 2006 Sep 8;281(36):26602-14 17167474 - Nature. 2006 Dec 14;444(7121):860-7 |
References_xml | – ident: 2022031208305031500_R7 doi: 10.1093/brain/awn012 – ident: 2022031208305031500_R14 doi: 10.1080/08977190701781222 – ident: 2022031208305031500_R25 doi: 10.1016/j.cmet.2007.06.002 – ident: 2022031208305031500_R22 – ident: 2022031208305031500_R23 doi: 10.1016/0026-0495(87)90063-1 – ident: 2022031208305031500_R5 doi: 10.1016/S0939-4753(04)80048-6 – ident: 2022031208305031500_R3 doi: 10.1016/S0140-6736(05)66378-7 – ident: 2022031208305031500_R20 doi: 10.1007/s00125-008-0928-9 – ident: 2022031208305031500_R11 doi: 10.1016/S0006-291X(03)01452-9 – ident: 2022031208305031500_R35 doi: 10.1210/jc.2004-1696 – ident: 2022031208305031500_R18 doi: 10.1210/jc.2006-1811 – ident: 2022031208305031500_R8 doi: 10.1002/humu.20651 – ident: 2022031208305031500_R10 doi: 10.1158/0008-5472.CAN-03-2364 – ident: 2022031208305031500_R1 doi: 10.1038/nature05485 – ident: 2022031208305031500_R16 doi: 10.2337/diabetes.54.8.2277 – ident: 2022031208305031500_R28 doi: 10.1038/nature05016 – ident: 2022031208305031500_R27 doi: 10.1210/edrv.21.6.0415 – ident: 2022031208305031500_R33 doi: 10.1016/j.bbrc.2006.01.012 – ident: 2022031208305031500_R34 doi: 10.1172/JCI26498 – ident: 2022031208305031500_R21 doi: 10.1073/pnas.0601752103 – ident: 2022031208305031500_R6 doi: 10.1110/ps.073295308 – ident: 2022031208305031500_R15 doi: 10.1042/bst0290072 – ident: 2022031208305031500_R12 doi: 10.1038/nm816 – ident: 2022031208305031500_R13 doi: 10.1007/s00109-003-0474-3 – ident: 2022031208305031500_R2 doi: 10.1089/met.2004.2.82 – ident: 2022031208305031500_R30 doi: 10.1152/physrev.90100.2007 – ident: 2022031208305031500_R31 doi: 10.1172/JCI200319246 – ident: 2022031208305031500_R17 doi: 10.2337/db06-0133 – ident: 2022031208305031500_R19 doi: 10.1074/jbc.M601284200 – ident: 2022031208305031500_R26 doi: 10.1017/S0007114500000982 – ident: 2022031208305031500_R4 doi: 10.1530/eje.1.02127 – ident: 2022031208305031500_R29 doi: 10.1038/nature05017 – ident: 2022031208305031500_R9 doi: 10.1111/j.1471-4159.2007.04968.x – ident: 2022031208305031500_R32 doi: 10.1038/sj.ijo.0803632 – ident: 2022031208305031500_R24 doi: 10.1007/s00125-001-0723-3 – reference: 18359860 - Protein Sci. 2008 Apr;17(4):711-24 – reference: 16556721 - Eur J Endocrinol. 2006 Apr;154(4):577-85 – reference: 15673055 - Nutr Metab Cardiovasc Dis. 2004 Oct;14(5):228-32 – reference: 3796297 - Metabolism. 1987 Jan;36(1):54-9 – reference: 16617105 - Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6676-81 – reference: 10889795 - Br J Nutr. 2000 Mar;83 Suppl 1:S71-7 – reference: 12017675 - Diabetes Care. 2000 Jan;23 Suppl 1:S4-19 – reference: 16427608 - Biochem Biophys Res Commun. 2006 Mar 10;341(2):507-14 – reference: 12914763 - Biochem Biophys Res Commun. 2003 Aug 29;308(3):409-13 – reference: 16809344 - J Biol Chem. 2006 Sep 8;281(36):26602-14 – reference: 18251005 - Diabetologia. 2008 Apr;51(4):641-7 – reference: 16691291 - J Clin Invest. 2006 Jun;116(6):1494-505 – reference: 18245784 - Brain. 2008 Mar;131(Pt 3):732-46 – reference: 11356130 - Biochem Soc Trans. 2001 May;29(Pt 2):72-5 – reference: 14679176 - J Clin Invest. 2003 Dec;112(12):1796-808 – reference: 18923185 - Physiol Rev. 2008 Oct;88(4):1379-406 – reference: 16731817 - Diabetes. 2006 Jun;55(6):1554-61 – reference: 11133069 - Endocr Rev. 2000 Dec;21(6):697-738 – reference: 18092235 - Growth Factors. 2007 Aug;25(4):280-5 – reference: 16046292 - Diabetes. 2005 Aug;54(8):2277-86 – reference: 12928786 - J Mol Med (Berl). 2003 Oct;81(10):600-12 – reference: 17593905 - Int J Obes (Lond). 2007 Sep;31(9):1420-8 – reference: 15671098 - J Clin Endocrinol Metab. 2005 Apr;90(4):2282-9 – reference: 14996734 - Cancer Res. 2004 Mar 1;64(5):1737-43 – reference: 18157829 - Hum Mutat. 2008 Jan;29(1):53-8 – reference: 17618858 - Cell Metab. 2007 Jul;6(1):79-87 – reference: 12524533 - Nat Med. 2003 Feb;9(2):225-9 – reference: 16862116 - Nature. 2006 Aug 24;442(7105):916-9 – reference: 17167474 - Nature. 2006 Dec 14;444(7121):860-7 – reference: 17953663 - J Neurochem. 2008 Jan;104(2):287-97 – reference: 17374712 - J Clin Endocrinol Metab. 2007 Jun;92(6):2240-7 – reference: 15836891 - Lancet. 2005 Apr 16-22;365(9468):1415-28 – reference: 18370640 - Metab Syndr Relat Disord. 2004 Jun;2(2):82-104 – reference: 16862115 - Nature. 2006 Aug 24;442(7105):920-4 – reference: 11935152 - Diabetologia. 2002 Feb;45(2):210-6 |
SSID | ssj0006060 |
Score | 2.358516 |
Snippet | Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue
Byung-Soo Youn 1 ,
Sa-Ik Bang 2 ,
Nora Klöting 3 ,... OBJECTIVE—Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated... Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated disturbances;... OBJECTIVE--Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated... OBJECTIVE— Progranulin is an important molecule in inflammatory response. Chronic inflammation is frequently associated with central obesity and associated... |
SourceID | pubmedcentral proquest gale pubmed pascalfrancis crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 627 |
SubjectTerms | Adiponectin - blood Adipose Tissue - physiopathology Adult Biological and medical sciences Blood pressure Body fat Breast cancer Care and treatment Cohort Studies Cross-sectional studies Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - genetics Diabetes Mellitus, Type 2 - physiopathology Diabetes. Impaired glucose tolerance Diagnosis Endocrine pancreas. Apud cells (diseases) Endocrinopathies Enzyme-linked immunosorbent assay Enzymes Etiopathogenesis. Screening. Investigations. Target tissue resistance Fatty Acids, Nonesterified - blood Female Fibroblasts Genetic aspects Glucose Glucose Intolerance - blood Glucose Intolerance - genetics Health aspects Humans Inflammation Inflammation - blood Inflammation - genetics Insulin resistance Intercellular Signaling Peptides and Proteins - blood Intercellular Signaling Peptides and Proteins - genetics Leptin - blood Lipids - blood Macrophages Macrophages - physiology Male Medical sciences Metabolic disorders Middle Aged Obesity Obesity - blood Obesity - genetics Obesity - physiopathology Obesity Studies Omentum - physiology Protein expression Proteins Reference Values Research design RNA, Messenger - genetics Tumor necrosis factor-TNF Type 2 diabetes |
Title | Serum Progranulin Concentrations May Be Associated With Macrophage Infiltration Into Omental Adipose Tissue |
URI | http://diabetes.diabetesjournals.org/content/58/3/627.abstract https://www.ncbi.nlm.nih.gov/pubmed/19056610 https://www.proquest.com/docview/216476984 https://www.proquest.com/docview/66974020 https://pubmed.ncbi.nlm.nih.gov/PMC2646061 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgkxAviO-FQbEADV6iLXY-n1BXbQxEtwltom-W44-1YiSFtA_899zFTragiodWbf1TFfvO5zv7_DtC3h2UCuMMFcbcsDBmpQrRyw-TLFMqKoyOWklPT9OTy_jLLJn53JzGp1V2NrE11LpWuEe-z5D4Ki3y-OPyV4hFo_Bw1VfQuEu2W-YyUOds1sdbB-CbuxsoEUMWzswRCzHOs31dIqtphEVVbi1HnVHumIIxUVI2MFbWFbnY5IX-m0x5a3U6fkgeeLeSjp0ePCJ3TPWY3Jv6g_Mn5AfYhPVPet5mY1WYfU4neGGx8qy5DZ3KP_TQ0E5cRtPvi9UcfsYaX3OwOvRzZRfXHg9fVjU9c5UB6FgvlnVj6EUrxafk8vjoYnIS-joLoQIxrcKygJiosNxqrqyVSWpShiw6WuMrYZmRLGNJnmtjAJAbkG0aa2kjaNBW8mdkq6ors0Oo1TLiukiysmRxCe6HipiWpVIcVkFmo4B86IZbKE9CjrUwrgUEIygZgZLBq9JZQN700KVj3tgE2kOZCWSyqDBVRrntFgH9m5yJMWgFSyFiLeDfhsAruW4akX_6OgC99yBbw1Mp6a8oQN-QJWuA3BsgrxxH-Cbg206bRLebfvMhyQUXKYNujAaK1ncYHAsI4VIekN1O84Q3Mo3op0RAXvetYB3wyEdWpl43Ik0hXoSIICDPnZbeDGUBri_4zgHJBvrbA5B3fNhSLeYt_zj40DC1ohf_faZdct8dvGG63kuytfq9Nq_Af1uVo3aWwns-iUZk-_Do9PzbX3dHSZU |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVAIuiDem0K54FC5W8fp9QCgNLQlN2gqlordlvY8motgBJ0L9UfxHZrK2W6OIWw-RkuzI2vHMzs7sznxDyKt3mcQ4Q7qBr5kbsEy66OW7YRxL6aVaeUtJjw6j_knw-TQ8XSN_6loYTKusbeLSUKtC4hn5DkPgqyhNgg-zny42jcLL1bqDhtWKA33xGyK28v3gI4j3NWP7e-Ne362aCrgS5jR3sxQCgNT4RvnSGBFGOmIIGaMUfkIWa8FiFiaJ0hoIEg2MRIESxoMBZYQPz71B1gMsaO2Q9d29w-MvjemHaMDWvHgMcT9jC2XEfD_eURniqHrYxuXKBlhvAzU2MaZmihKkY2xbjVV-77_pm1f2w_275E7lyNKu1bx7ZE3n98nNUXVV_4B8Byu0-EGPl_lfOea70x6WSOYVTm9JR-KC7mpaK4hW9Ot0PoG_savYBOwcHeRmel7Rw495QY9sLwLaVdNZUWo6XurNQ3JyLUJ4RDp5kesnhBolPF-lYZxlLMjA4ZEeUyKT0od9lxnPIW_r181lBXuO3TfOOYQ_KBmOksHi7NghLxrSmcX6WEW0jTLjiJ2RY3KOtAc8HPjrHfGul4Ysghg5hae1Cc_Eoix58mnYInpTEZkCZiVFVRQBvCEuV4tyu0V5ZlHJVxG-rLWJ1-f3l1_ChPs8YsDGZkvRGobBlYGgMfIdslFrHq_MWsmbReiQrWYU7BFeMolcF4uSRxFEqBCDOOSx1dLLV5mCsw3eukPilv42BIh03h7Jp5Ml4jl47bC0vKf_ndMWudUfj4Z8ODg82CC37bUfJgs-I535r4V-Dt7jPNus1iwl367bTPwF32eH_w |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcEG9MoV3xKFys1Lt-HhAKKaGhTdtDK3Jb7H00EcUOOBHqT-PfMeO13RpF3HqIlGQ_Wbue2dmZ3dlvCHm9m0mMM6Trc81cn2XSRS_fDaJISi_RyqskPT4K98_8L5Ngskb-NHdhMK2ysYmVoVaFxD3yHkPiqzCJ_Z6psyJO9oYf5j9dLCCFB61NNQ2rIQf68jdEb-X70R6I-g1jw0-ng323LjDgSujfws0SCAYSw43i0pg0CHXIkD5GKfwELNIpi1gQx0prAMQaBhX6KjUeNCiTcnjuLXI74uBUwVSKJm2stwtxgb394jFkAI0sqRHjPOqpDBlVPSzocm0pbBaEhqUYkzTTEuRkbIGNVR7wv4mc11bG4T1yt3Zpad_q4H2ypvMHZGNcH9o_JN_BHi1_0JMqEyzHzHc6wMuSec3YW9Jxekk_atqoilb062wxhb-xvtgULB4d5WZ2UePhx6Kgx7YqAe2r2bwoNT2tNOgRObsRETwm63mR66eEGpV6XCVBlGXMz8D1kR5TaSYlhxWYGc8h75rXLWRNgI51OC4EBEIoGYGSwWvakUNettC5Zf1YBdpBmQlk0chRIaXd6hEwvsGx6HtJwEKIlhN4Whd4ni7LUsSfDzugtzXIFNArmdbXI2BsyNDVQe50kOeWn3wV8FWjTaLZyb_6EsSCi5DBMLY6itYOGJwaCB9D7pDNRvNEbeBK0U5Hh2y3rWCZ8LgpzXWxLEUYQqwK0YhDnlgtvXqVCbjd4Lc7JOrobwtAzvNuSz6bVtzn4L_D1PKe_bdP22QDjIM4HB0dbJI79vwPswafk_XFr6V-AW7kItuqJiwl327aQvwFP7-Kxg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+progranulin+concentrations+may+be+associated+with+macrophage+infiltration+into+omental+adipose+tissue&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Youn%2C+Byung-Soo&rft.au=Bang%2C+Sa-Ik&rft.au=Kloting%2C+Nora&rft.au=Park%2C+Ji+Woo&rft.date=2009-03-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.volume=58&rft.issue=3&rft.spage=627&rft_id=info:doi/10.2337%2Fdb08-1147&rft.externalDocID=A195267179 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |